Publications: Sequential Monitoring of Tumor Marker Status During Therapy

• SABCS 2023: Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer

• ASCO 2023:  Sequential monitoring of tumor macrophage fusion cells in the circulation of metastatic breast cancer and their prognostic value

• Tri-Con 2019: Changes in the type of circulating cancer associated macrophage-like cells during and after radiation therapy is associated with progression in thoracic cancers

• Tri-Con 2019: Real time monitoring of solid tumor progression using circulating stromal cells in early and late stage disease